Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma

靶向线粒体 Lon 蛋白酶作为胶质母细胞瘤的新疗法

• 批准号: 10406778
• 负责人: Daniela Annenelie Bota
• 金额: $ 7.18万
• 依托单位: UNIVERSITY OF CALIFORNIA-IRVINE
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-01 至 2025-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10406778
• 关键词: Award; Funding; Glioblastoma; Mitochondria; Parents; Research; endopeptidase La; novel therapeutics; supplemental instruction

The supplement instructions PA‐21-071 state: “At minimum, the Research Strategy section should be completed and must include a summary or abstract of the funded parent award or project. Other sections should also be included if they are being changed by the proposed supplement activities.” The original Project Summary document has not changed as a result of the proposed supplement activities.

补充说明PA-21-071指出：“至少，研究策略部分 应填写完整，并必须包括受资助的父母奖的摘要或摘要，或 项目如果其他部分被拟议的 补充活动”。 原项目摘要文件没有因拟议的 补充活动。